Eupraxia Pharmaceuticals, Inc. (EPRX)
8.50
+0.38
(+4.68%)
USD |
NASDAQ |
Feb 20, 16:00
8.50
0.00 (0.00%)
After-Hours: 20:00
Eupraxia Pharmaceuticals Shareholders Equity (Quarterly) : 90.03M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 365.77M |
| enGene Holdings, Inc. | 167.71M |
| Achieve Life Sciences, Inc. | 33.62M |
| Oncolytics Biotech, Inc. | 0.0827M |
| Edesa Biotech, Inc. | 13.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.35M |
| Total Liabilities (Quarterly) | 3.906M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 23.98 |
| Net Debt Paydown Yield | 0.30% |